VOICE2VOICE

Serial Number 77893555
Registration 3983244
800

Registration Progress

Application Filed
Dec 15, 2009
Under Examination
Approved for Publication
Apr 12, 2011
Published for Opposition
Apr 12, 2011
Registered
Jun 28, 2011

Trademark Image

VOICE2VOICE

Basic Information

Serial Number
77893555
Registration Number
3983244
Filing Date
December 15, 2009
Registration Date
June 28, 2011
Published for Opposition
April 12, 2011
Renewal Date
June 28, 2021
Drawing Code
4000

Status Summary

Current Status
Active
Status Code
800
Status Date
Jul 12, 2021
Registration
Registered
Classes
044 045

Rights Holder

CSL Behring GmbH

03
Address
76, Emil-von Behring Strasse
Marburg D-35401
DE

Ownership History

CSL Behring GmbH

Original Applicant
03
Marburg DE

CSL Behring GmbH

Owner at Publication
03
Marburg DE

CSL Behring GmbH

Original Registrant
03
Marburg DE

Legal Representation

Attorney
Scott D. Woldow

USPTO Deadlines

Next Deadline
2013 days remaining
Section 8 & 9 Renewal Due (Principal Register) (Based on registration date 20110628)
Due Date
June 28, 2031
Grace Period Ends
December 28, 2031

Application History

35 events
Date Code Type Description Documents
Jul 12, 2021 NA89 E NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED Loading...
Jul 12, 2021 RNL1 Q REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) Loading...
Jul 12, 2021 89AG O REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED Loading...
Jul 9, 2021 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Apr 2, 2021 E89R I TEAS SECTION 8 & 9 RECEIVED Loading...
Jun 28, 2020 REM2 E COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED Loading...
Apr 26, 2019 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Apr 26, 2019 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Dec 18, 2018 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Dec 18, 2018 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Aug 8, 2017 NA85 E NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED Loading...
Aug 8, 2017 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Loading...
Aug 8, 2017 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Jun 27, 2017 E815 I TEAS SECTION 8 & 15 RECEIVED Loading...
Jul 6, 2016 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jul 6, 2016 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jun 28, 2016 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
Sep 21, 2011 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jun 28, 2011 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Apr 12, 2011 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Apr 12, 2011 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 10, 2011 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Mar 9, 2011 ALIE A ASSIGNED TO LIE Loading...
Feb 11, 2011 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 23, 2010 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Aug 23, 2010 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Aug 23, 2010 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Aug 20, 2010 DOCK D ASSIGNED TO EXAMINER Loading...
Feb 25, 2010 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Feb 25, 2010 GNRT F NON-FINAL ACTION E-MAILED Loading...
Feb 25, 2010 CNRT R NON-FINAL ACTION WRITTEN Loading...
Feb 22, 2010 DOCK D ASSIGNED TO EXAMINER Loading...
Dec 24, 2009 MPMK O NOTICE OF PSEUDO MARK MAILED Loading...
Dec 23, 2009 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Dec 18, 2009 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 044
Healthcare information services, namely, advice and consultation with new patients and caregivers regarding the use and administration of immunoglobulins for the treatment of immune deficiencies in humans and diseases where immune modulating treatment is required
First Use Anywhere: Nov 30, 2008
First Use in Commerce: Nov 30, 2008
Class 045
Providing personal support services for patients with life threatening disorders and their caregivers, namely, emotional support regarding the use and administration of immuoglobulins for the treatment of immune deficiencies in humans and diseases where immune modulating treatment is required
First Use Anywhere: Nov 30, 2008
First Use in Commerce: Nov 30, 2008

Additional Information

Pseudo Mark
VOICE TO VOICE

Classification

International Classes
044 045